Monitoring Nanoparticle-Treated Hepatocarcinoma Cells for Apoptosis

互联网2014-02-13

402

This chapter describes a method for monitoring nanoparticle treated human hepatocarcinoma cells (Hep G2) for apoptosis. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.

相关产品推荐

FAS/FAS蛋白/Apo-1 antigen (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD_antigen: CD95 APT1) (FAS1) (TNFRSF6)蛋白/Recombinant Human Tumor necrosis factor receptor superfamily member 6 (FAS)重组蛋白

￥69

CD24/CD24蛋白/(Small cell lung carcinoma cluster 4 antigen) (CD24A)蛋白/Recombinant Human Signal transducer CD24 (CD24)-Nanoparticle (Active)重组蛋白

￥69

SCGB1A1,CC10,CCSP,UGB/SCGB1A1,CC10,CCSP,UGB蛋白Recombinant Human Uteroglobin protein (SCGB1A1) (Active)重组蛋白Clara cell phospholipid-binding protein, Clara cells 10 kDa secretory protein, CC10, Secretoglobin family 1A member 1, Urinary protein 1蛋白

￥852

Tricostatin A（TSA）处理和未处理的细胞裂解液|Tricostatin A (TSA) Treated And Untreated Cell Lysates

￥11

PHLDA1/PHLDA1蛋白/Apoptosis-associated nuclear protein Proline- and glutamine-rich protein PHRIP, TDAG51蛋白/Recombinant Human Pleckstrin homology-like domain family A member 1 (PHLDA1)重组蛋白

￥69